Treatment of CIN3 with Endocervical Involvement and HPV 16

Primary Treatment Approach

Ablative methods, such as cryotherapy or laser ablation, cannot adequately treat disease extending into the endocervical canal and are associated with higher rates of subsequent invasive cancer diagnosis, according to the American College of Obstetricians and Gynecologists, with a strength of evidence level of moderate 1, 2
Excisional procedures, such as LEEP, cold-knife conization, or laser conization, allow pathologic examination to exclude microinvasive or occult invasive carcinoma, which occurs in up to 7% of CIN2/3 cases with unsatisfactory colposcopy, as recommended by the American College of Obstetricians and Gynecologists 3
The American College of Obstetricians and Gynecologists recommends excisional procedures for CIN3 with endocervical involvement, as they provide a tissue specimen for pathologic examination, with a high level of evidence 1, 2, 3

LEEP is a suitable excisional option, with shorter operative time and less blood loss, but may have more frequently involved margins, according to the American College of Obstetricians and Gynecologists, with a strength of evidence level of high 1, 3
Cold-knife conization is another acceptable option, with clearer margin interpretation, though longer operative time and more bleeding, as recommended by the American College of Obstetricians and Gynecologists, with a moderate level of evidence 1, 3
Laser conization is equivalent in efficacy to other excisional methods, according to the American College of Obstetricians and Gynecologists, with a high level of evidence 1, 3

The National Comprehensive Cancer Network recommends follow-up utilizing either cytology at 6 months or HPV DNA testing at 12 months, with a high level of evidence 4
HPV testing, especially for HPV 16, at 6 months post-LEEP is highly sensitive for detecting recurrent CIN2+, according to the National Comprehensive Cancer Network, with a strength of evidence level of high 4
Combination testing, including HPV and cytology, provides the highest sensitivity but lower specificity, as recommended by the National Comprehensive Cancer Network, with a moderate level of evidence 4

For positive margins on excision specimen, the National Comprehensive Cancer Network recommends cervical cytology at 6 months with consideration of endocervical curettage, and re-excision if invasion is suspected, with a high level of evidence 4
For negative margins, standard surveillance with cytology at 6 months or HPV testing at 12 months is recommended, according to the National Comprehensive Cancer Network, with a high level of evidence 2, 4

The American College of Obstetricians and Gynecologists recommends follow-up without treatment as the preferred approach for CIN-1 with satisfactory colposcopy, with follow-up options including repeat Pap tests at 6 and 12 months or HPV DNA testing at 12 months 5, 6, 7
For CIN-1, a combination of repeat cytology and colposcopy at 12 months is an acceptable alternative follow-up approach, and the decision to treat persistent CIN-1 should be based on patient and provider preferences after discussing risks and benefits 6, 7
Acceptable treatment modalities for CIN-1 include cryotherapy, laser ablation, LEEP, electrofulguration, and cold coagulation, with endocervical sampling recommended before any ablative procedure 6, 7, 8
Excisional modalities, such as LEEP, are preferred for recurrent CIN-1 after previous ablative therapy 6, 8

The American College of Obstetricians and Gynecologists recommends that both excision and ablation are acceptable for CIN-2,3 with satisfactory colposcopy, with excisional modalities preferred for recurrent CIN-2,3 5, 8
Diagnostic excisional procedures are recommended for CIN-2,3 with unsatisfactory colposcopy, and observation of CIN-2,3 with sequential cytology and colposcopy is unacceptable except in special circumstances 8
Hysterectomy is unacceptable as primary therapy for CIN-2,3, and follow-up after treatment should use either cytology or a combination of cytology and colposcopy at 4-6 month intervals until at least 3 cytologic results are negative 8

The natural history of CIN-2 is that about 43% regress without treatment, 35% persist, and 22% progress to carcinoma in situ or invasive cancer 9

Hysterectomy should be avoided as primary treatment for CIN-1 or CIN-2,3, and ablative procedures should be avoided for CIN-1 with unsatisfactory colposcopy 6, 8
Podophyllin or podophyllin-related products should not be used on the cervix or vagina, and repeat conization or hysterectomy should not be performed based on a single positive HPV test 6, 7, 9
Under-treatment of CIN-2,3 should be avoided, as these lesions are more likely to persist or progress than to regress 10, 9

The American College of Obstetricians and Gynecologists recommends using blended current settings, such as Endocut Q mode, effect 2-3, cut duration 1, cut interval 4, to minimize thermal artifact and bleeding risk in LEEP procedures, with a maximum wattage of 30-50 watts for cervical procedures 11
Blended currents are preferred over pure cutting currents because pure cutting current causes rapid transection with increased likelihood of immediate bleeding requiring intervention, according to the American Gastroenterological Association 12, 13, 14
Microprocessor-controlled units, such as Endocut mode, provide superior results by alternating short cutting bursts with prolonged coagulation periods and limiting peak voltage based on impedance feedback, as recommended by the American Gastroenterological Association 15

The American College of Obstetricians and Gynecologists recommends using Endocut Q mode with effect 2-3, cut duration 1, and cut interval 4, to balance adequate tissue cutting with hemostasis while minimizing char formation in LEEP procedures 16

Conventional blended currents produce better margin evaluability compared to microprocessor-controlled currents, though both are acceptable, according to the American Gastroenterological Association 12, 13, 14
Lower effect settings and controlled cut intervals reduce thermal spread and char formation, as recommended by the American Gastroenterological Association 15, 16

The American College of Obstetricians and Gynecologists recommends never using pure cutting current alone, as it causes rapid transection with minimal coagulation, leading to immediate bleeding requiring intervention 12, 13, 14
Excessively high wattage settings should be avoided, as they increase thermal damage and char formation, according to the American Gastroenterological Association 11, 16

The American College of Obstetricians and Gynecologists recommends ensuring all electrosurgical generators have saved, clearly labeled programs with consistent settings to avoid errors and ensure reproducibility, as suggested by the American Gastroenterological Association 12, 13, 14